PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsWhole fetal genome sequenced for the first time

BioNews

Whole fetal genome sequenced for the first time

Published 5 March 2013 posted in News and appears in BioNews 660

Author

Dr Daniel Grimes

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Researchers have sequenced the entire genome of an 18 and a half-week-old fetus using DNA samples from the blood of its mother and saliva samples from its father. These findings provide a proof of principle that a fetus can be examined for genetic defects using non-invasive technologies...

Researchers have sequenced the entire genome of an 18 and a half-week-old
fetus using DNA samples from the blood of its mother and saliva samples from
its father. These findings provide a proof of principle that a fetus can be
examined for genetic conditions using non-invasive technologies.

Currently, non-invasive screening is used to detect conditions where
there is an extra copy of a chromosome, known as trisomy - including Down's
syndrome, where there are three copies of chromosome 21.

This study, published in Science Translational Medicine, shows that it
is possible to non-invasively sequence the whole genome of a fetus and to use
that to check for smaller changes in the DNA, including more than 3000 single gene disorders.

'If the genome is a book, and a trisomy is an extra chapter, we want to
find every typo', lead researcher Dr Jay Shendure of the University of
Washington in Seattle told New Scientist.

Single gene, or Mendelian, disorders affect around one
percent of live births, and include cystic fibrosis and Huntington's disease.
Currently, a small number of specific Mendelian disorders are screened for during
pregnancy, but this requires the use of invasive procedures that increase the
risk of miscarriage

The team of researchers, primarily based at the University of
Washington, exploited the fact that around 13 percent of DNA in a pregnant
woman's blood plasma - known as cell-free DNA - originates from the fetus.

Looking for small variations in the letters of the genetic code, they compared
the sequence of the cell-free DNA to the mother's DNA, which was sequenced from
a blood sample, and so would be 100 percent her own. Any variants found in the
cell-free DNA but not in the DNA from the mother's blood were assumed to have
come from the fetus.

Further confirmation that these were sections of DNA from the fetus was
made by comparing variants to the father's DNA, which was sequenced from a
saliva sample. Variants unique to him that appeared in the cell-free DNA must
have been inherited by the fetus.

After birth, the baby's genome was sequenced from cord blood, showing
their predictions were 98 percent accurate. They also tested their techniques
on a second pregnant woman with an 8.2-week-old fetus, with 95 percent
accuracy, which suggests these methods could be used to screen very young fetuses.

As well as heritable variants, the researchers looked for spontaneous
mutations, identifying 39 of the 44 that were discovered after birth. However,
both the New York Times and Science Now reported that they also identified 25
million false positives.

Dr Shendure suggested that the technique could be available in the
clinic within five years, estimating the cost at $50,000 per child. However, he
warned that the ability to read the genome and find genetic variants far out-strips
our ability to understand the consequences on the development and health of a
child. 'There will be many mutations whose impact we just don't know', he told
Science Now.

Professor Dennis Lo, the pathologist who first discovered that fetal DNA circulates
in the mother's blood, has urged caution. Speaking to Science Now, he said: 'I
don't think it would be ethical to use this to screen for late-onset diseases
like Alzheimer's or cardiovascular diseases, for example'.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
13 February 2015 • 2 minutes read

Whole-genome sequencing detects de novo mutations in embryos

by Nina Chohan

Scientists have shown for the first time that whole-genome sequencing (WGS) in IVF embryos can detect 'de novo' mutations...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
13 March 2013 • 2 minutes read

Fetal genome sequenced using only a blood sample from the mother

by Dr Lux Fatimathas

US researchers have for the first time sequenced the genome of a fetus using only a blood sample from the mother. It is hoped this new form of non-invasive sampling could allow doctors to screen for a range of genetic diseases prenatally, with minimal risk to the fetus...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 March 2013 • 2 minutes read

Genetic map of all microbes on, or in, our bodies published

by Dr Louisa Petchey

The most extensive catalogue of the trillions of microbes that live in and on humans - called the human microbiome - has been published by an international team of scientists...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 January 2013 • 2 minutes read

Global study counters 'junk' DNA theory

by Emma Stoye

Scientists have found that 80 percent of DNA in the human genome, previously thought to be of no use, have important functions...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
22 November 2012 • 3 minutes read

Reflections on the ethical debate surrounding non-invasive prenatal genetic diagnosis

by Professor Vardit Ravitsky

An up-and-coming technology will soon allow genetic testing of a fetus with a simple maternal blood test early in the first trimester of the pregnancy by isolating cell-free fetal DNA in the mother's plasma. Currently, obtaining reliable diagnostic genetic information requires invasive testing with Chorionic Villus Sampling (CVS) or amniocentesis. Both carry a risk of miscarriage and are performed between weeks 10 and 20 of the pregnancy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
18 June 2009 • 3 minutes read

Non-invasive prenatal diagnosis using cell-free fetal DNA: implications for parents

by Jane Fisher

Antenatal Results and Choices (ARC) is the only UK charity providing non-directive information and support to parents before, during and after antenatal testing and when an abnormality is diagnosed in an unborn baby. We have 20 years' experience of talking to parents on our National Helpline on all aspects of...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on Auguste Rodin's 'The Thinker').
CC BY 4.0
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on the sculpture 'The Thinker' by Auguste Rodin).
Comment
18 June 2009 • 4 minutes read

Advances in non-invasive prenatal diagnosis and care: free fetal DNA

by Dr Philippa Brice

Antenatal care in the UK includes various forms of screening intended to assess the health of the mother and fetus; at present this includes the use of ultrasound imaging to check on physical development of the fetus, and serum screening using maternal blood to determine blood group, identify the presence...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
Comment
18 June 2009 • 3 minutes read

Free fetal DNA for non-invasive prenatal diagnosis (NIPD): ethical aspects

by Dr Zuzanna Deans and 1 others

Dr Phillipa Brice's accompanying commentary highlights how non-invasive testing of free fetal DNA (ffDNA) in pregnancy could transform women's experiences of antenatal screening and prenatal diagnosis. NIPD is already available for foetal sex, rhesus D blood type and some Mendelian conditions such as achondroplasia, with tests for aneuploidy detection and...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on Auguste Rodin's 'The Thinker').
CC BY 4.0
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1997. Depicts the gyri of the Thinker's brain as a maze of choices in biomedical ethics (based on the sculpture 'The Thinker' by Auguste Rodin).
News
9 June 2009 • 2 minutes read

Progress in non-invasive pregnancy tests

by Dr Jess Buxton

Non-invasive prenatal tests to identify fetuses at risk of genetic disorders as early as the sixth week of pregnancy are now a reality, say British scientists. A team based at the Institute of Child Health in London and Bristol has successfully carried out simple blood tests...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Gene modification helps mouse mum tolerate fetus

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

4 July 2022 • 2 minutes read

USA scrambles to understand implications of Roe v Wade on fertility industry

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856